Clinical Trial Update: Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

Ongoing Phase 2/3 clinical study evaluating transarterial chemoembolization (TACE) with ABCB1 inhibition versus TACE alone for hepatocellular carcinoma; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Hepato Cellular Carcinoma (HCC) | Phase 2, Phase 3 | Status: RECRUITING